Earnings Overview

Financial DataActualYoYEstimates
EPS23.29-3.49%21.69
Revenue71.63B-2.43%73.29B
EBIT---

News

 
 
 
 
 
 

Market Insights

What's the highlight of Santen Pharmaceutical Co., Ltd.'s financial report?
Talk to TigerGPT
Start

Exclusive Benefits

 

 
 

Analyst Forecast

Analyst Price Targets

Data Last updated:
 
 
 
 

Analyst Recommendations

 
 
 
 
 
 
 
 

Relevant Information

 
 
 

Feedback

Welcome to share with us your comments or feedback

*T&Cs Apply. Capital at Risk, Not Investment Advice.